Related Experiment Video
Updated: Mar 19, 2026

11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.9K
Summary
PD-L1 inhibitor atezolizumab shows effectiveness in first-line treatment for advanced bladder cancer. Nearly 25% of patients ineligible for cisplatin achieved durable responses, indicating a promising therapeutic option.
Area of Science:
- Oncology
- Immunotherapy
Background:
- Advanced bladder cancer often presents challenges in treatment, particularly for patients ineligible for platinum-based chemotherapy.
- The programmed death-ligand 1 (PD-L1) pathway is a key target in cancer immunotherapy.
Framework:
- Phase II clinical study evaluating atezolizumab, a PD-L1 inhibitor.
- Focus on patients with advanced bladder cancer unsuitable for cisplatin chemotherapy.
Implementation:
- Atezolizumab administered as first-line therapy.
- Assessment of response rates and durability.
Implications:
- Atezolizumab demonstrates efficacy as a first-line treatment option for cisplatin-ineligible advanced bladder cancer patients.
- Durable responses observed in a significant proportion of patients suggest long-term benefit.
Related Concept Videos
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Urinary Bladder
4.1K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
4.1K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K

